FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043329185> ?p ?o ?g. }

• W2043329185 endingPage "2" @default.
• W2043329185 startingPage "1" @default.
• W2043329185 abstract "Disease activity in the rheumatic diseases can be defined as a reversible state, manifested by clinical, laboratory, or radiographical features. Disease activity occurs principally as a result of immunologic and inflammatory processes involving specific organs at a specific point in time. The multifaceted nature of clinical presentations in adults as well as in pediatric rheumatic diseases makes the assessment of disease activity challenging. Nevertheless, this assessment is fundamental in patient care and based on the use of valid, reliable, and interpretable instruments. The use of disease activity instruments enables clinicians, patients, and researchers to quantify and evaluate disease activity in a standardized way. The application of these instruments in a clinical care and research setting presents several challenges: namely, the administrative burden of the instrument, including the preparedness and skillfulness of the assessor, the mode of administration, the time required to complete the instrument, and the complexity of scoring. All of these factors need to be taken into consideration when choosing an instrument applicable in a particular setting.In the last decade, we have witnessed the emergence of a plethora of instruments developed to measure disease activity in the rheumatic diseases. This special issue contains five papers: four related to the assessment of activity in adult rheumatic diseases and one paper with a focus on pediatric rheumatic disease. Wong et al. “Measuring disease activity in psoriatic arthritis” provide a detailed review of the assessment of disease activity in psoriatic arthritis. Their paper highlights the currently available tools for the assessment of the various rheumatologic and dermatologic aspects of the disease and discusses the composite indices that have been developed, or are still under development.Dowsey and Choong “The utility of outcome measures in total knee replacement surgery” discuss the utility of outcome measures for total knee replacement surgery, most commonly performed to treat osteoarthritis. While the majority of patients have a substantial improvement in symptoms following this procedure, a proportion of patients report ongoing pain and poor function. The authors remind us that accurate and reproducible measurement of residual pain and functional impairment in patients undergoing arthroplasty forms an important basis for optimizing outcomes of this procedure. The paper by Dowsey et al. challenges our perception of disease “activity” in the rheumatic diseases and allows us to consider the overlap with the broader concept of “severity,” particularly in osteoarthritis, which does not traditionally follow a relapsing-remitting course. In an original research article, Ohrndorf et al. “Detailed joint region analysis of the 7-joint ultrasound score: evaluation of an arthritis patient cohort over one year” use ultrasound technique, specifically the 7-joint ultrasound (US7) score, to evaluate disease activity and the presence of erosions over one year in a cohort of patients with predominantly rheumatoid and psoriatic arthritis. They demonstrate a high synovitis score at baseline in the majority of patients, which diminishes over one year of treatment, corresponding with a decline in the DAS28 score. The responsiveness over time of ultrasound-based assessment of disease activity in inflammatory arthritis, compared with clinical-laboratory based assessment, and the prognostic significance of mild persistent synovitis detectable on ultrasound are yet to be conclusively demonstrated and quantified. However, the study by Ohrndorf et al. highlights the potential usefulness of imaging modalities in assessment of activity in the rheumatic diseases. Quimby et al. “Comparison of the systemic lupus erythematosus activity questionnaire and the systemic lupus erythematosus disease activity index in a black barbadian population” evaluate the use of the Systemic Lupus Activity Questionnaire (SLAQ), vis-a-vis the internationally accepted and validated Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and the physician global assessment (PGA). They conclude that SLAQ results in over-reporting of symptoms and is an inadequate disease monitoring tool. They underscore the use of laboratory measurements and highlight the need for a modified version that would be valid, feasible, and available to countries most burdened by SLE, yet least equipped to diagnose and manage the disease. Finally, Luca's and Feldman's “Disease activity measures in paediatric rheumatic diseases” provide a comprehensive review of assessment of disease activity in the pediatric population. Their paper explains the theoretical framework required for the development of disease activity measures citing the challenges encountered in this particular patient population. In addition, they summarize the most common disease activity measures used for Juvenile Idiopathic Arthritis (JIA), Juvenile Systemic Lupus Erythematosus (JSLE), and Juvenile Dermatomyositis (JDM) reminding us that more research is needed to determine the most appropriate measures to be used in clinical practice and the research environment.The assessment of disease activity in rheumatic diseases is very challenging but essential. Significant achievements have been made in improving the measurement properties of the instruments. Further research is needed to identify the measurement tools that are of the highest quality and can be conveniently used in clinics and in research studies." @default.
• W2043329185 created "2016-06-24" @default.
• W2043329185 creator A5000939681 @default.
• W2043329185 creator A5002210479 @default.
• W2043329185 creator A5003819915 @default.
• W2043329185 creator A5014281693 @default.
• W2043329185 date "2013-01-01" @default.
• W2043329185 modified "2023-09-27" @default.
• W2043329185 title "The Assessment of Disease Activity in Rheumatic Diseases" @default.
• W2043329185 cites W117628105 @default.
• W2043329185 cites W1510398127 @default.
• W2043329185 cites W1825102967 @default.
• W2043329185 cites W1825470796 @default.
• W2043329185 cites W1830706163 @default.
• W2043329185 cites W1834703168 @default.
• W2043329185 cites W1857313533 @default.
• W2043329185 cites W1889952835 @default.
• W2043329185 cites W1894750122 @default.
• W2043329185 cites W1903167817 @default.
• W2043329185 cites W1903207539 @default.
• W2043329185 cites W1925218046 @default.
• W2043329185 cites W1954511783 @default.
• W2043329185 cites W1965683411 @default.
• W2043329185 cites W1968932142 @default.
• W2043329185 cites W1972542512 @default.
• W2043329185 cites W1973987518 @default.
• W2043329185 cites W1976422995 @default.
• W2043329185 cites W1980403066 @default.
• W2043329185 cites W1984251209 @default.
• W2043329185 cites W1985004174 @default.
• W2043329185 cites W1993999106 @default.
• W2043329185 cites W1995307078 @default.
• W2043329185 cites W2001131937 @default.
• W2043329185 cites W2003717175 @default.
• W2043329185 cites W2005598541 @default.
• W2043329185 cites W2005662519 @default.
• W2043329185 cites W2007082452 @default.
• W2043329185 cites W2015531561 @default.
• W2043329185 cites W2023881662 @default.
• W2043329185 cites W2024714476 @default.
• W2043329185 cites W2026641908 @default.
• W2043329185 cites W2030797830 @default.
• W2043329185 cites W2038962823 @default.
• W2043329185 cites W2041790004 @default.
• W2043329185 cites W2043035301 @default.
• W2043329185 cites W2044668285 @default.
• W2043329185 cites W2045082873 @default.
• W2043329185 cites W2046069192 @default.
• W2043329185 cites W2052949576 @default.
• W2043329185 cites W2054242247 @default.
• W2043329185 cites W2058212772 @default.
• W2043329185 cites W2062239820 @default.
• W2043329185 cites W2067327580 @default.
• W2043329185 cites W2071061180 @default.
• W2043329185 cites W2073688197 @default.
• W2043329185 cites W2073700972 @default.
• W2043329185 cites W2074638729 @default.
• W2043329185 cites W2086134882 @default.
• W2043329185 cites W2091985144 @default.
• W2043329185 cites W2092661515 @default.
• W2043329185 cites W2096991001 @default.
• W2043329185 cites W2099045655 @default.
• W2043329185 cites W2099148197 @default.
• W2043329185 cites W2100789920 @default.
• W2043329185 cites W2105480874 @default.
• W2043329185 cites W2107819073 @default.
• W2043329185 cites W2108075643 @default.
• W2043329185 cites W2110793425 @default.
• W2043329185 cites W2110828087 @default.
• W2043329185 cites W2113365862 @default.
• W2043329185 cites W2113376150 @default.
• W2043329185 cites W2113717019 @default.
• W2043329185 cites W2116679877 @default.
• W2043329185 cites W2118247287 @default.
• W2043329185 cites W2119062509 @default.
• W2043329185 cites W2119067278 @default.
• W2043329185 cites W2120422600 @default.
• W2043329185 cites W2121699204 @default.
• W2043329185 cites W2124807661 @default.
• W2043329185 cites W2127359359 @default.
• W2043329185 cites W2128325185 @default.
• W2043329185 cites W2128840310 @default.
• W2043329185 cites W2129001709 @default.
• W2043329185 cites W2139308359 @default.
• W2043329185 cites W2139384965 @default.
• W2043329185 cites W2149148432 @default.
• W2043329185 cites W2151553299 @default.
• W2043329185 cites W2154464235 @default.
• W2043329185 cites W2154552358 @default.
• W2043329185 cites W2154814233 @default.
• W2043329185 cites W2157439109 @default.
• W2043329185 cites W2157686760 @default.
• W2043329185 cites W2161369617 @default.
• W2043329185 cites W2165902528 @default.
• W2043329185 cites W2167948681 @default.
• W2043329185 cites W2169977205 @default.
• W2043329185 cites W2171675095 @default.
• W2043329185 cites W2171762906 @default.

• next